Lipopolysaccharide (LPS) is the major cell surface glycolipid of gram-negative bacteria. However, the cell surface of all gram-negative enteric bacteria contains an additional glycolipid, the phosphoglyceride-linked enterobacterial common antigen (ECA PG ) (16, 21, 24, 32) (Fig. 1A) (19, 22, 32) . Individual ECA polysaccharide chains are covalently linked to diacylglycerolphosphate via a glycosidic linkage between the potential reducing terminal GlcNAc residue and the phosphate residue of the aglycone (16, 17, 30) ; the phosphoglyceride aglycone anchors the ECA chains to the outer membrane (2, 33) . Accordingly, phosphoglyceride-linked ECA chains are referred to as ECA PG . While the function of ECA PG remains to be established, recent studies suggest that it may be involved in the resistance of Shiga toxin-producing Escherichia coli O157:H7 to organic acids (6) .
Many of the genes involved in the assembly of ECA polysaccharide chains in E. coli are located in the wec gene cluster located at 85.4 min on the E. coli K-12 chromosome (8) , and the functions of these genes have been determined in considerable detail (3, 29, 32) . The ECA trisaccharide repeat unit is assembled as an undecaprenylpyrophosphate-linked intermediate (lipid III) (Fig. 1B) (4, 5, 31, 32) . Accordingly, synthesis of the repeat unit is initiated by the transfer of GlcNAc 1-P from UDP-GlcNAc to undecaprenylphosphate to yield undecaprenylpyrophosphate-GlcNAc (lipid I) catalyzed by WecA (5, 31, 32) . Subsequent reactions involve the successive transfer of ManNAcA and Fuc4NAc from the donors UDP-ManNAcA and TDP-Fuc4NAc, catalyzed by WecG and WecF, respectively.
Although synthesis of lipid III occurs on the cytosolic face of the cytoplasmic membrane, currently available information suggests that Wzy-catalyzed polymerization of repeat units to form linear polysaccharide chains occurs on the periplasmic face of the membrane. This requires the transbilayer movement of lipid III to the periplasmic face of the membrane, and it has been suggested that this step is mediated by a "flippase" encoded by the wzxE gene (o416) (20) . Finally, polymerization is followed by the transfer of polysaccharide chains from the lipid carrier to an as yet unidentified acceptor to yield phosphoglyceride-linked chains, and the completed ECA PG molecules are then translocated to the outer membrane. However, essentially nothing is known regarding the genes and mechanisms involved in the latter two steps.
ECA PG is regarded as the major form of ECA, and it is present in all gram-negative enteric bacteria (16) . ECA PG accounts for approximately 0.2% of the cellular dry weight of E. coli K-12 (18, 22) . Two related forms, ECA LPS and ECA CYC , have also been identified in certain organisms. ECA LPS molecules possess the same linear ECA polysaccharide chains found in ECA PG , but in the case of ECA LPS these chains are covalently linked to the core region of LPS (15, 16) instead of a phosphoglyceride aglycone. In contrast, ECA CYC is a watersoluble polymer that contains only ECA trisaccharide repeat units (16) . In addition, the degree of polymerization of ECA-CYC molecules is quite different from that observed for linear ECA polysaccharide chains. For example, the polysaccharide chains of ECA PG synthesized by E. coli K-12 exhibit a population that ranges from 1 to 14 repeat units in length, with a modal value of 5 to 7 repeat units (3) . In contrast, ECA CYC molecules isolated from Shigella sonnei contain only four to six trisaccharide repeat units (11) .
Although the structure of ECA CYC has been characterized, nothing is known about its function, and there is no information available regarding the genetics and biosynthesis of this novel molecule. This is due, in large part, to the general belief that the occurrence of ECA CYC within members of the Enterobacteriaceae is rather restricted, since it has only been found in cell extracts of Shigella sonnei phase I (11, 19) , Yersinia pestis (39) , and Plesiomonas shigelloides (7, 37) ; the last organism has now been included in the Enterobacteriaceae.
The results presented in this communication describe the occurrence and characterization of ECA CYC in E. coli strain B as determined by a variety of methods, including nuclear magnetic resonance (NMR) spectroscopy and electrospray ionization mass spectrometry (ESI-MS). ECA CYC was initially found to copurify with the C-terminal PAS (Per-Arnt-Sim) domain of the human hypoxia-inducible factor 2 (HIFd) (38) following its overexpression as a recombinant protein in E. coli B. However, the detection of ECA CYC in these preparations was fortuitous because it was not found to be associated with HIFd and its synthesis was independent of the overexpression of this protein. ECA CYC was also found in cell extracts of E. coli K-12, and similar to the results obtained with E. coli B, its synthesis was independent of the overexpression of HIFd. Finally, the results of genetic and biochemical analyses show for the first time that the trisaccharide repeat units of ECA CYC and ECA PG are assembled by a common biosynthetic pathway.
MATERIALS AND METHODS
Bacterial strains, growth conditions, and plasmids. E. coli strains used in this study are listed in Table 1 . Transductions were carried out with phage P1 vir according to Silhavy et al. (36) . Introduction of plasmid pKG31 into recipient strains was carried out either by transformation or electroporation with standard procedures. Cultures for the routine propagation of bacteria were grown at 37°C in Luria-Bertani (LB) broth or on LB agar containing 0.2% glucose (28) . Where indicated, 15 N-labeled protein and 13 C-labeled ECA were isolated from cells grown in M9 minimal medium (28) containing 0.1% 15 NH 4 Cl and 0.3% glucose (either natural abundance 13 C or uniformly labeled [99%] with 13 C [Cambridge Isotope Laboratories]). Tetracycline, ampicillin, and chloramphenicol were added to media when appropriate to give final concentrations of 10 g/ml, 50 g/ml, and 30 g/ml, respectively.
Plasmid pKG31 was constructed based on sequence alignments and secondary-structure predictions that identified a minimal PAS domain within human HIF2 from amino acids 240 to 350. The DNA sequence for this domain was amplified by PCR and inserted in a modified form of the pHis-parallel 1 expression vector (35) where the His 6 tag was replaced by the ␤1 domain of streptococcal protein G (GB1). The resulting plasmid contains GB1 and HIFd separated by a 13-amino-acid linker that contains a tobacco etch virus protease cleavage site, allowing facile removal of the fusion and linker from HIFd during purification.
Purification of cyclic ECA. ECA CYC was found to copurify with GB1-HIFd following its overexpression in E. coli strains PR4185 and PR4186 (Table 1) . GB1-HIFd fusion protein expression was induced by adding 0.5 mM isopropyl-␤-D-galactopyranoside in 1 liter of either LB or M9 minimal medium containing 15 NH 4 Cl and [
13 C]glucose (either natural abundance or 99% enriched and uniformly labeled), and expression was allowed to proceed overnight at 20°C. The cells were harvested by centrifugation and handled at 4°C for all remaining purification steps. The pellet was resuspended in 25 ml of 50 mM sodium phosphate buffer (pH 7.6)-15 mM NaCl-5 mM dithiothreitol, lysed by highpressure extrusion, centrifuged, and filtered (0.22 m), and the supernatant was purified with a Source 15Q anion-exchange column (Amersham Biosciences) preequilibrated with the above buffer. GB1-HIFd eluted from the column during the course of washing the column with 2 volumes of the same buffer. Proteincontaining fractions were pooled and concentrated in an Amicon pressure-driven ultrafiltration cell with YM10 10-kDa filters. The concentrated GB1-HIFd was digested with tobacco etch virus protease (13), followed by removal of the cleaved GB1 fragment by passage of the digest through an immunoglobulin G-Sepharose affinity column (Amersham Biosciences). HIFd, which eluted in the flowthrough volume of this column, was concentrated in an Amicon ultrafiltration system with a YM3 3-kDa filter and then loaded onto a HiLoad 26/60 Superdex 75 column (Amersham Biosciences) equilibrated in 50 mM sodium phosphate buffer (pH 7.2)-15 mM NaCl-5 mM dithiothreitol. The chromatographic mobility of HIFd was consistent with an apparent molecular mass of 14.3 kDa, which agreed with the predicted monomeric molecular mass to within 8%. Chromatograms were obtained by monitoring the UV absorbance at 280 nm (⌭ 280 of HIFd ϭ 16,170 M Ϫ1 cm Ϫ1 ), and protein-containing fractions were analyzed for HIFd by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE). In addition, the identity of purified HIFd samples was verified by ESI-MS.
ECA CYC was isolated from 30 mg of 15 N-labeled protein (purified as described above) by ethanol extraction (70% ethanol, 5 min at 80°C). Denatured protein was removed by centrifugation at 10,000 ϫ g at 4°C. Ethanol was removed from the supernatant solution by rotary evaporation at 50°C, and the aqueous phase was then lyophilized. The polysaccharide was further purified by reverse-phase high-pressure liquid chromatography (HPLC) (Vydac C18 column, 0.5 by 25 cm) with a linear gradient of 0 to 5% acetonitrile in H 2 O. The chromatogram was obtained by monitoring the absorbance from 190 to 600 nm, and the carbohydrate-containing fractions eluting from this column were identified by their absorbance at 206 nm. The presence of ECA in these samples was confirmed by one-dimensional 1 H-NMR spectroscopy. NMR spectroscopy. All NMR experiments were recorded on Varian Inova 500-and 600-MHz spectrometers, generally at 27°C. NMR spectra of the ECA CYC that copurified with HIFd were recorded in samples containing 0.8 mM protein in 50 mM sodium phosphate (pH 7.2)-15 mM NaCl-5 mM dithiothreitol-10% D 2 O. NMR spectroscopic analysis of HPLC-purified ECA CYC was performed on a sample that contained the polysaccharide at a final concentration of approximately 100 M. ECA samples were dissolved in 550 l of either 99.96% D 2 O or H 2 O:D 2 O (90:10, by volume) mixtures. One-dimensional 1 H-NMR spectra were recorded with presaturation of the water resonance during the 2-s relaxation delay. Two-dimensional total correlation spectroscopy spectra were recorded with an MLEV-17 spin-lock pulse sequence (7 and 100 ms), and two-dimensional nuclear Overhauser enhancement spectroscopy spectra were recorded with a mixing time of 300 and 500 ms. Carbon and nitrogen chemical shift assignments were based on 1 H-13 C and 1 H-15 N heteronuclear single-quantum coherence (HSQC) spectra, respectively. Additional chemical shift data were obtained from standard three-dimensional NMR experiments generally used to assign protein backbone and side chain atoms, including HNCACB, CBCA(CO)NH, HNCO (34) , and (HBCBCA)COCAHA (14) . Chemical shifts were referenced to the methyl-1 H signals of sodium 2,2-dimethyl-2-silapentane 5-sulfonate, with direct referencing for all 1 H shifts and indirect referencing for 15 N and 13 C shifts (23) . Crude cell lysate NMR samples were prepared from 200-ml cultures of BL21(DE3) or HMS174(DE3) cells transformed with pKG31 that were allowed to grow overnight at 20°C in M9 minimal medium containing 15 NH 4 Cl, with and without induction of GB1-HIFd fusion protein expression. Cells were harvested, lysed, centrifuged, and filtered as described before. The supernatant was concentrated to 0.5 ml and used to record standard 1 H-15 N HSQC spectra (12) . Mass spectrometry. A Micromass Quattro II Triple quadrupole mass spectrometer (Micromass) equipped with the manufacturer's electrospray source was used for ESI-MS experiments. Samples were dissolved in 48% methanol and 4% ammonium hydroxide for ESI-negative ion analysis. Samples were continuously introduced into the source at a rate of 5 l/min by an infusion pump (Harvard Apparatus), and mass spectra were acquired over an m/z range of 300 to 1,700 per 5 s.
FACE analyses. ECA samples were hydrolyzed at 100°C with 0.1, 0.25, 0.5, and 1.0 N HCl for 30 min and then dried under reduced pressure with a Speed Vac apparatus (Savant Instruments). The hydrolyzed samples were analyzed by fluorophore-assisted carbohydrate electrophoresis (FACE) with a FACE apparatus, oligosaccharide profiling kit, and reagents according to the directions of the manufacturer (Glyko). Accordingly, reducing termini were labeled with the neutral fluorophore 2-aminoacridone and then resolved on an oligosaccharide profiling gel. Labeled oligosaccharides were detected on the gel, and electronic images of the gel were generated with a Bio-Rad Fluor-S Multi-Imager equipped with a 530DF60 filter.
RESULTS

Copurification of ECA with HIFd.
HIFd is believed to play an integral role in the function of human hypoxia-inducible factor 2, a eukaryotic transcription factor that responds to reduced intracellular oxygen levels (38) . To conduct structural studies of this domain, we expressed the 13.2-kDa HIFd protein fragment in E. coli PR4186 ( signals in these spectra generated by the three 15 N/ 1 H pairs clearly indicated that they were from amides linked to groups not normally found within protein samples. This is demonstrated in segments of CBCA(CO)NH and HNCACB spectra corresponding to these amides, which show that each 15 N/ 1 H pair has only a single carbon at approximately 25 ppm present on the distal side of the amide linkage rather than the two expected C ␣ and C ␤ signals (Fig. 2B) .
1 H-13 C HSQC spectra show that this carbon is directly attached to protons at approximately 2 ppm, establishing that it is an N-acetyl group. The triple resonance spectra (Fig. 2B ) also indicated that each amide had three signals to the proximal side, one from a C ␣ -like site (Ϸ55 ppm) and two from C ␤ -like sites (Ϸ70 and 100 ppm). All of these data are clearly inconsistent with standard amino acid structure, strongly suggesting that this sample contained nonprotein material.
To identify the source of these signals, we purified this material by ethanol extraction and reverse-phase HPLC to obtain a protein-free sample. A one-dimensional 1 H-NMR spectrum of this material showed a typical carbohydrate pattern, including very intense signals at approximately 2 ppm corresponding to various N-acetyl groups (Fig. 3) . Three characteristic signals corresponding to anomeric protons indicated that this compound contained three monosaccharides. These signals appeared with equal intensities at 4.86, 4.97, and 5.12 ppm, indicating that the monosaccharides were present in equal amounts. The identities of these were provided by preliminary monosaccharide composition analyses conducted on this NMR sample. These revealed that the carbohydrate contained three N-acetylated amino sugars in equal amounts: N-acetylglucosamine, 4-acetamido-4,6-dideoxyhexosamine, and N-acetylhexosamine uronic acid. Glucose was also detected in lesser amounts (data not shown).
To more completely assign the NMR chemical shifts of this carbohydrate, we used a combination of two-dimensional homonuclear and heteronuclear NMR methods. (37) and Yersina pestis (39) and also with the 13 C assignments reported for Plesiomonas shigelloides ECA PG (7) ( Table 2) . However, a comparison of these chemical shift assignments of ECA CYC revealed small variations that are likely due to heterogeneity occurring from natural modifications, possible degradation during purification, and variations in experimental conditions.
To confirm the glycosidic linkages for this polysaccharide, we acquired several nuclear Overhauser enhancement spectroscopy spectra. Strong interresidue nuclear Overhauser enhancement contacts (particularly those for Fuc4NAc H1-ManNAcA H4, ManNAcA H1-GlcNAc H3, and GlcNAc H1-Fuc4NAc H3) were observed in agreement with linkages identified in ECA (Fig. 1A) . Interestingly, the nuclear Overhauser enhancement spectroscopy cross peaks had the same sign as the diagonal peaks, indicating a global rotational correlation time corresponding to a molecular mass above Ϸ1.5 kDa. From these observations, we conclude that the carbohydrate material present in purified preparations of HIFd is an ECA polysaccharide.
Identification of cyclic ECA. As discussed earlier, ECA PG is a component of the cell surface of all gram-negative enteric bacteria (16, 21, 24, 32) . In addition to ECA PG , the occurrence of ECA LPS has also been reported in certain members of the Enterobacteriaceae, including E. coli K-12 (15, 16) . However, it is important to emphasize that the occurrence of ECA CYC has been demonstrated in only a few organisms (11, 16, 19, 37, 39) , and it has not been identified in E. coli. Therefore, we conducted experiments to determine if indeed the water-soluble ECA that was present in HIFd preparations obtained from E. coli B was ECA CYC .
Analyses of the HIFd-copurifying ECA by ESI-MS provided strong evidence that this material was ECA CYC . Accordingly, mass spectra of ECA present in HIFd samples prior to ethanol extraction and HPLC purification revealed molecular ions of mass 2,430 Ϯ 1 Da, 2,472 Ϯ 1 Da, 2,514 Ϯ 1 Da, 2,556 Ϯ 1 Da, and 2,598 Ϯ 1 Da, in a ratio of approximately 1:2:6:3:1, respectively. The molecular ion of 2,430 Ϯ 1 Da is in agreement with that calculated for ECA CYC containing four trisaccharide repeat units (2,429 Da). Partial O-acetylation at the C-6 of GlcNAc has been previously described as a common modification of ECA (11, 19) and would result in a mass increase of 42 Da for a single acetylation event. Thus, the observed molecular ions correspond to cyclic ECA molecules containing four trisaccharide repeat units substituted with one, two, three, and four O-acetyl groups, respectively. Molecular ions for five or six repeat units, which have been reported for ECA CYC from Shigella sonnei (37), were not found in the mass spectra of ECA CYC from E. coli. In this regard, it should be noted that the ECA CYC obtained from Plesiomonas shigelloides was also found to contain only four repeat units (37) . However, the basis for the apparent organism-dependent variation in the degree of polymerization is not understood.
Additionally, NMR analysis of the ECA isolated by copurification with HIFd confirmed that this material is indeed ECA CYC . Aside from ECA CYC , all other forms of ECA (including ECA PG , ECA LPS , and various biosynthetic intermediates) are extremely hydrophobic due to the chemical nature of the lipid molecules to which they are linked. These forms of ECA are poorly soluble, and they form large micelles in aqueous solution that would dramatically increase the line width and decrease the signal-to-noise ratio of NMR signals. As evidence of this, Basu et al. used high temperature (70°C) and large sample tubes (10 mm diameter) to record a one-dimensional 13 C spectrum of ECA PG (7) . In contrast, HIFd-associated ECA gave highly resolved NMR spectra at 27°C in a standard 5-mm NMR tube (Fig. 3A) . Moreover, the 1 H onedimensional and 1 H-13 C HSQC spectra of the ECA material did not reveal 1 H and 13 C signals of aliphatic groups, which are typically found between 1 and 2 ppm for 1 H and around 30 ppm for 13 C, that would be indicative of the lipid components of ECA PG and ECA LPS (7) . In addition, 31 P-NMR analysis of HIFd-associated ECA did not indicate the presence of phosphodiesters, which would be expected to occur in both ECA PG and ECA LPS , or phosphomonesters, which would be expected to occur in ECA LPS (data not shown).
Finally, it is important to note that ECA PG , ECA LPS , and ECA CYC are characterized by the absence of a free terminal reducing sugar. Indeed, no signals for terminal reducing sugar residues were detected in the 1 H-and 13 C-NMR spectra obtained from the ECA associated with purified preparations of HIFd. The lack of a free reducing terminus was confirmed by FACE analyses. In this method, saccharides and oligosaccharides are labeled at the reducing terminus with the appropriate fluorescent probe to yield a derivative with a net negative charge, and the fluorescent derivative is then analyzed by gel electrophoresis. The electrophoretic mobility of the derivative is dependent on its charge-mass ratio as well as its hydrodynamic volume. Fluorescent labeling of HIFd-associated ECA with 2-aminoacridone proved to be unsuccessful (Fig. 4, lane  6) , consistent with the lack of a free reducing terminus. In contrast, mild acid treatment of HIFd-associated ECA generated several oligosaccharide fragments with free reducing termini, as indicated by the 2-aminoacridone-labeled products shown in Fig. 4, lanes 2 We note that the FACE results here could possibly be produced by a new form of linear ECA which has its reducing end blocked by a novel modification. However, such modification would lead to unique NMR signals from the terminal Fuc4NAc, particularly for the anomeric proton. No such signals were observed (Fig. 3) . Furthermore, the molecular mass of such a molecule would be significantly above 2,447 Da (molecular ion of unmodified linear polymer), which is not supported by our ESI-MS data.
In summary, these data establish that ECA purified in this manner does not consist of a linear ECA polysaccharide that was generated by some uncharacterized degradative process. Rather, we conclude that the HIFd-associated polysaccharide consists of ECA CYC molecules, each of which contains four trisaccharide repeat units and an average of approximately two O-acetyl groups.
Synthesis of ECA CYC in E. coli B and K-12 strains is independent of HIFd overexpression. ECA CYC has not been previously identified in E. coli. Accordingly, the data presented thus far raise questions as to whether ECA CYC biosynthesis is limited to E. coli B strains or is induced by HIFd overexpression. To address these questions, the soluble fraction of cell lysates of E. coli B strain BL21(DE3) and E. coli K-12 strain HMS174(DE3) cultures transformed with pKG31 were analyzed for ECA CYC , with and without induction of HIFd overexpression. NMR analysis of 15 N-labeled cell lysates showed intense amide signals characteristic of soluble ECA CYC in 15 N-1 H HSQC spectra of HMS174(DE3) lysates independent of HIFd expression (Fig. 5) . Similar results were obtained for BL21(DE3) lysates (data not shown). The chemical shift values of the amide 15 N and 1 H resonances of ECA CYC overlaid very closely and were unaffected by HIFd ( Fig. 2A and 5 ), suggesting that there is no interaction between ECA CYC and HIFd. In these spectra, additional signals from other nitrogen-containing metabolites or small proteins can be observed. These data demonstrate that HIFd overexpression has no effect on ECA CYC biosynthesis and that ECA CYC is present in both E. coli B and K-12 strains. Genetic loci involved in synthesis of ECA CYC . A considerable amount is known about the genes involved in synthesis of the linear ECA chains of ECA PG and ECA LPS (3, 8, 29, 32) . In contrast, essentially nothing is known about the genetic determinants of ECA CYC . The wecA, wecF, and wecG genes of E. coli K-12 encode the GlcNAc 1-P, Fuc4NAc, and ManNAcA transferases, respectively, that are involved in the assembly of the ECA trisaccharide repeat unit of linear ECA polysaccharide chains (Fig. 1B) (8, 26, 27) . Accordingly, null mutations in these genes completely abolish the synthesis of ECA PG and ECA LPS (26, 27, 29) , as determined by a variety of assays, including colony immunoblot assay (25) , passive hemagglutination assay (31) , and SDS-PAGE and fluorography analyses of cell envelopes prepared from cells grown in the presence of radiolabeled GlcNAc (31) . However, it is not known whether these genes also function for the synthesis of ECA CYC .
In this regard, it should be noted that the relatively small size of ECA CYC and the lack of a hydrophobic aglycone component of ECA CYC preclude its detection by many of the methods used to study the biosynthesis of the other ECA forms. In addition, it is not yet known whether the antibodies used for the colony immunoblot and passive hemagglutination assays recognize ECA CYC . Accordingly, HIFd was overexpressed in strains PR4153 (wecA::Tn10/pKG31), PR4164 (wecG::Tn10/pKG31), and PR4161 (wecF::Tn10/pKG31) grown in the presence of 15 NH 4 Cl, and attempts were made to detect the presence of 15 N-ECA CYC in cell extracts of each of these strains as revealed in 1 H-15 N HSQC spectra. No N-acetyl signals attributable to ECA were detected in any of these preparations (data not shown). These observations corroborate the conclusion stemming from NMR studies described earlier that the carbohydrate material present in purified preparations of HIFd is indeed an ECA polysaccharide. Furthermore, these findings provide the first evidence that the trisaccharide repeat unit of both ECA CYC and linear ECA polysaccharide chains is assembled by a common pathway.
DISCUSSION
ECA PG is a cell surface component of all gram-negative enteric bacteria (16) , and it accounts for approximately 0.2% of the cellular dry weight of E. coli K-12 (18, 22) . In contrast, ECA CYC has thus far been found to occur in only a few members of the Enterobacteriaceae (11, 16, 19, 39) . The data presented in this study now demonstrate that ECA CYC is also synthesized by E. coli, and it is entirely possible that future studies will reveal that ECA CYC is a constituent of many other gram-negative enteric bacteria. The apparent limited occurrence of ECA CYC among members of the Enterobacteriaceae may simply reflect the fact that only a few organisms have been examined for the presence of ECA CYC because of the lack of readily available assays for its detection.
ECA CYC was initially found to copurify with the C-terminal PAS domain of the human hypoxia-inducible factor 2 (HIFd) (38) following its overexpression as a recombinant protein in E. coli B. However, detailed analysis of the NMR spectra of HIFd, including three-dimensional 15 N-and 15 N, 13 C-edited nuclear Overhauser enhancement spectroscopy spectra, did not reveal interactions between ECA CYC and HIFd. Furthermore, NMR analyses revealed strong signals for ECA CYC in the soluble fraction obtained from crude cell lysates of both E. coli strains B and K-12 in the absence of HIFd synthesis. These data indicate that the synthesis of ECA CYC is independent of the overexpression of HIFd, and they also suggest that its occurrence in E. coli is not strain specific.
Subsequent work has revealed that the methods used here to purify HIFd were chiefly responsible for the fortuitous discovery of ECA CYC in E. coli K-12. Accordingly, the initial anionexchange step for the isolation of the fusion protein, GB1-HIFd, is not very efficient because the protein binds weakly to the Source 15Q anion-exchange resin with the described phosphate buffer. Subsequent refinements of the isolation protocol employed a lower-ionic-strength buffer (50 mM Tris, pH 7.6), which resulted in increased binding of the protein to the resin without concomitant binding of ECA CYC , allowing the separation of these molecules from one another (P. Erbel, unpublished results). In contrast, attempts to employ gel filtration chromatography and molecular cutoff filters to separate the highly negatively charged and unusually shaped ECA CYC (2.4 kDa to 2.6 kDa) from HIFd (13.2 kDa) were unsuccessful.
Bruix et al. (10) were also unsuccessful in their initial attempts to use size exclusion chromatography to separate ECA from the comparably sized chemotactic protein CheY (14.0 kDa) from E. coli. CheY-associated ECA was ultimately isolated by repeated phenol extraction of the protein (9), generating material that was identified as a linear and lipid-free ECA polysaccharide. It is significant to note that these investigators identified a free reducing terminal Fuc4NAc residue (␣-anomer at 5.23 ppm and ␤-anomer at 4.77 ppm) in their purified preparations. Since GlcNAc is the potential reducing terminal amino sugar of ECA trisaccharides, this observation suggests the possibility that these polysaccharides resulted from degradation of ECA CYC that was originally present in the fractions containing CheY. All of these data suggest that ECA CYC could be a more general contaminant in samples of other recombinant proteins expressed in E. coli.
ECA CYC is readily identified by characteristic signal doubling in a 1 H-15 N HSQC spectrum (Fig. 2) , possibly caused by chemical heterogeneity (e.g., differential O-acetylation) and restrained rotational motion around the C-N bonds of N-acetyl groups. In this context, it is interesting that Staaf and colleagues (7, 37) suggested that ECA CYC undergoes slow conformational changes based on NMR and molecular dynamics studies on unlabeled ECA CYC isolated from Plesiomonas shigelloides. Accordingly, such slow conformational exchange processes might also account for the signal doubling observed in this study.
Based on the molar extinction coefficient of HIFd at 280 nm, the amount of purified HIFd from 1 g (wet weight) of cells was calculated to be approximately 15 mg. Consequently, the amount of ECA CYC can be estimated from the peak volumes of the N-acetyl signals of ECA CYC relative to the protein backbone amide signals (ratio is 1:2) in 1 H-15 N HSQC spectra ( Fig. 2A) . With this ratio, and taking into account both the average molecular mass of ECA CYC and the fourfold redundancy of the N-acetyl signals, it was estimated that approximately 0.4 mg of ECA CYC was isolated from 200 mg (dry weight) of E. coli cells. Surprisingly, this suggests that ECA CYC and ECA PG are present in similar amounts in E. coli. It is important to stress that nothing is known about possible fac-tors that may affect the amounts of ECA CYC and ECA PG synthesized by cells. Thus, a more accurate determination of the cellular quantity of these molecules will require direct assays as well as additional information about the possible regulation of their synthesis.
This investigation revealed that the trisaccharide repeat units of ECA CYC and linear ECA polysaccharide chains are assembled as a lipid-linked intermediate (lipid III) by a common biosynthetic pathway that involves enzymes encoded by the wecA, wecG, and wecF genes of the wec gene cluster of E. coli K-12. Although it has previously been assumed that these genes play a role in ECA CYC synthesis, there in fact exists no direct evidence to validate this assumption. Accordingly, the data presented here constitute the first information regarding genetic loci involved in the synthesis of this molecule.
It is highly likely that the pathways for the assembly of water-soluble ECA CYC and the linear ECA chains of ECA PG and ECA LPS diverge following synthesis of lipid III. Indeed, it has been suggested that ECA CYC may be a component of the cytoplasm (1, 16) . In this event, it seems likely that the assembly of ECA CYC would most likely occur on the inner leaflet of the cytoplasmic membrane by a WzyE-independent mechanism, and it would not require WzxE-mediated translocation of lipid III across the cytoplasmic membrane. It also seems reasonable to assume that the enzyme that catalyzes the cyclization reaction is specifically involved in the synthesis of ECA CYC . In this regard, the functions of essentially all of the genes in the wec gene cluster have been defined, and none of these genes appear to be specifically involved in the assembly of ECA CYC . Therefore, genetic determinants specifically involved in the synthesis of this polymer must be located at sites on the chromosome outside of this gene cluster; however, these genetic loci have not yet been identified.
The functions of ECA CYC and ECA PG are not known, and attempts to identify their functions would be greatly facilitated by the availability of mutants specifically defective in the synthesis of either of these molecules. However, as stated above, the identification of genetic determinants specifically involved in the assembly of ECA CYC has yet to be accomplished. In addition, the isolation of mutants specifically defective in the synthesis of ECA PG has also proven to be problematic. Accordingly, the wzyE and wzxE genes encode the polymerase and putative flippase involved in the assembly of linear ECA polysaccharide chains, respectively. Although mutations in these genes specifically abolish the synthesis of ECA PG , recent experiments have revealed that the use of such mutants to investigate the functions of ECA CYC and ECA PG is not feasible because mutations in these genes are deleterious to the cell; this appears to be due to toxicity resulting from the accumulation of lipid III (P. D. Rick, unpublished results). Furthermore, attempts to isolate mutants specifically defective in the synthesis of ECA PG due to the inability to transfer ECA polysaccharide chains to a diacylglyceride or phosphoglyceride acceptor have not yet been successful.
Despite these obstacles, the discovery that ECA CYC is synthesized by E. coli K-12 now affords a tractable experimental system that will greatly facilitate efforts to identify the function of this novel molecule as well as to define the genes and enzymes involved in its assembly.
